Clinical Trial Update: Introduction of Protein S100 in Diagnostics in Minor Brain Injury Patients at Our Hospital

View source ↗

Summary

A completed clinical trial at Kantonsspital Münsterlingen evaluating the use of protein S100 as a diagnostic biomarker in intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Snippet

Sponsor: Kantonsspital Münsterlingen | Conditions: Intracerebral Hemorrhage | Status: COMPLETED